Workflow
November 25, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against MGX
MetagenomiMetagenomi(US:MGX) GlobeNewswire News Roomยท2024-11-06 18:18

Core Points - Metagenomi, Inc. (NASDAQ: MGX) is facing a class action lawsuit following the termination of its collaboration with Moderna, which was a significant aspect of its business model [3][4] - The company completed its initial public offering (IPO) on February 13, 2024, selling 6.25 million shares at $15 per share, but the stock price fell from $7.04 to $6.17 within a day after the announcement of the collaboration termination [3] Group 1 - The lawsuit is on behalf of shareholders who purchased stock during the class period from February 9 to 13, 2024, related to Metagenomi's IPO [2][4] - The termination of the collaboration with Moderna was unexpected and raised concerns about Metagenomi's future prospects [3] - The Gross Law Firm is leading the class action, emphasizing its commitment to protecting investors' rights against deceitful practices [5] Group 2 - Shareholders are encouraged to register for the class action by November 25, 2024, to potentially become lead plaintiffs [4] - The firm offers portfolio monitoring software to keep registered shareholders updated on the case's progress [4] - The lawsuit highlights the importance of accurate disclosures and the impact of misleading statements on stock performance [5]